Novel systemic sclerosis drugs: an overview of what might be to come

Home > Rheumatology > EULAR 2018

Read the full Report (pdf)

European League Against Rheumatism 13-16 June 2018 Amsterdam, the Netherlands

Featured articles

Letter from the Editor

Editor

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Conference

EULAR 2018

24 August, 2018 23:29

Online First

Rheumatoid Arthritis

Early, intensive rheumatoid arthritis treatment seems to normalise mortality rates

Trial

COBRA

Conference

EULAR 2018

24 August, 2018 23:36

Switching to biosimilar bDMARDs is safe and efficacious

Presented By

Prof. Kvien, University of Oslo and Diakonhjemmet Hospital, Norway

Trial

Phase 4, NOR-SWITCH

Conference

EULAR 2018

24 August, 2018 22:46

No significant differences when tapering TNF blockers versus csDMARDs

Presented By

Dr Van Mulligen, Erasmus MC, the Netherlands

Conference

EULAR 2018

24 August, 2018 21:51

Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey

Conference

EULAR 2018

24 August, 2018 20:26

Biologic drug levels and infection risk, and clinical effectiveness of sarilumab

Trial

TARGET

Conference

EULAR 2018

24 August, 2018 19:30

Confirmation of long-term safety profile adalimumab across indications

Presented By

Prof. Gerd Burmester, Charité University Hospital, Free University and Humboldt University of Berlin, Germany

Conference

EULAR 2018

24 August, 2018 18:39

Ankylosing Spondylitis

Clinical effect of vedolizumab on articular manifestations spondyloarthritis associated with IBD

Presented By

Dr. Paccou, Amiens University Medical Center, France

Conference

EULAR 2018

24 August, 2018 23:43

Synergistic effect NSAIDs plus TNFi in slowing radiographic progression in ankylosing spondylitis patients

Presented By

Dr Gensler, University of California San Francisco Medical Center, USA

Conference

EULAR 2018

24 August, 2018 22:48

Low bone mineral density is common in axial spondyloarthritis; more awareness required

Trial

Cohort study, axSpA

Conference

EULAR 2018

24 August, 2018 20:52

Osteoporosis and Osteoarthritis

Osteoporosis and vertebral fractures associated with disease activity/radiographic damage in axial spondyloarthritis

Conference

EULAR 2018

24 August, 2018 23:38

Glucosepane is a new biomarker for the severity of osteoarthritis

Conference

EULAR 2018

24 August, 2018 22:40

miRNA-146A plays key role in bone metabolism and osteoporosis

Conference

EULAR 2018

24 August, 2018 21:42

Systemic Sclerosis and Systemic Lupus Erythematosus